PDF(Pubmed)
Abstract：
BACKGROUND: Methylenedioxymethamphetamine (MDMA) is a popular drug worldwide and use is prevalent in Aotearoa New Zealand. Although associated with some significant harms, including fatalities, MDMA is ultimately less harmful than other commonly consumed drugs. We aimed to expand the understanding of MDMA harm and harm reduction strategies from a consumer perspective so that national harm reduction efforts can be better informed.
METHODS: We conducted 14 semi-structured focus group discussions including 60 people (aged 18-67, median = 21) who use MDMA in the Southern region of Aotearoa New Zealand to explore their thoughts and experiences regarding MDMA associated harm and harm reduction. Reflexive thematic analysis was conducted from a critical realist perspective.
RESULTS: Five themes were generated; (1) Mindset and setting matters; (2) Looking after your body and mind, not overdoing it; (3) Other substances increase risk and harm; (4) Trusted friends and peers are protective; and (5) Valid information is key for healthy self-determination; and one subtheme 5.1) Drug checking is essential harm reduction.
CONCLUSIONS: We discuss the implications for MDMA consumers and aim to inform national drug policy and the harm reduction practices of consumers and organisations, for the ultimate purpose of reducing MDMA-related harm in Aotearoa New Zealand.
METHODS: We conducted 14 semi-structured focus group discussions including 60 people (aged 18-67, median = 21) who use MDMA in the Southern region of Aotearoa New Zealand to explore their thoughts and experiences regarding MDMA associated harm and harm reduction. Reflexive thematic analysis was conducted from a critical realist perspective.
RESULTS: Five themes were generated; (1) Mindset and setting matters; (2) Looking after your body and mind, not overdoing it; (3) Other substances increase risk and harm; (4) Trusted friends and peers are protective; and (5) Valid information is key for healthy self-determination; and one subtheme 5.1) Drug checking is essential harm reduction.
CONCLUSIONS: We discuss the implications for MDMA consumers and aim to inform national drug policy and the harm reduction practices of consumers and organisations, for the ultimate purpose of reducing MDMA-related harm in Aotearoa New Zealand.
摘要：
背景：亚甲二氧基甲基苯丙胺（MDMA）是全球流行的药物，在新西兰奥特亚罗阿的使用很普遍。尽管与一些重大危害有关，包括死亡,MDMA最终比其他常用药物危害小。我们旨在从消费者的角度扩大对MDMA危害和减少危害战略的理解，以便更好地了解国家减少危害的努力。
方法：我们进行了14次半结构化焦点小组讨论，包括60名在新西兰奥特罗阿南部地区使用MDMA的人（年龄18-67岁，中位数=21），以探讨他们对MDMA相关危害和减少危害的想法和经验。反思性主题分析是从批判的现实主义角度进行的。
结果：产生了五个主题；（1）心态和设定事项；（2）照顾您的身心，不要过度使用；（3）其他物质会增加风险和伤害；（4）受信任的朋友和同伴具有保护作用；（5）有效的信息是健康自决的关键；一个子主题5.1）药物检查是减少伤害的关键。
结论：我们讨论了对MDMA消费者的影响，并旨在为国家药物政策以及消费者和组织的减少危害实践提供信息。最终目的是减少新西兰奥特罗阿与摇头丸有关的伤害。
方法：我们进行了14次半结构化焦点小组讨论，包括60名在新西兰奥特罗阿南部地区使用MDMA的人（年龄18-67岁，中位数=21），以探讨他们对MDMA相关危害和减少危害的想法和经验。反思性主题分析是从批判的现实主义角度进行的。
结果：产生了五个主题；（1）心态和设定事项；（2）照顾您的身心，不要过度使用；（3）其他物质会增加风险和伤害；（4）受信任的朋友和同伴具有保护作用；（5）有效的信息是健康自决的关键；一个子主题5.1）药物检查是减少伤害的关键。
结论：我们讨论了对MDMA消费者的影响，并旨在为国家药物政策以及消费者和组织的减少危害实践提供信息。最终目的是减少新西兰奥特罗阿与摇头丸有关的伤害。
